Glenmede Trust’s Insmed INSM Stock Holding History

Glenmede Trust’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$313K	Buy	1,916 +98	+5%	+$15.1K	﹤0.01%	1138
2025 Q4	$316K	Buy	+1,818	New	+$332K	﹤0.01%	1117
2025 Q1	$881K	Buy	11,550 +6,799	+143%	+$520K	﹤0.01%	740
2024 Q4	$328K	Buy	+4,751	New	+$342K	﹤0.01%	1064
2020 Q4	–	Sell	-862	Closed	-$27K	–	1714
2020 Q3	$27K	Buy	862 +35	+4%	+$1.01K	﹤0.01%	1498
2020 Q2	$22K	Sell	827 -739	-47%	-$17.5K	﹤0.01%	1550
2020 Q1	$37K	Hold	1,566	–	–	﹤0.01%	1809
2019 Q4	$37K	Hold	1,566	–	–	﹤0.01%	1809
2019 Q3	$27	Hold	1,566	–	–	﹤0.01%	1906
2019 Q2	$40	Hold	1,566	–	–	﹤0.01%	1789
2019 Q1	$45	Hold	1,566	–	–	﹤0.01%	1731
2018 Q4	$20	Buy	+1,566	New	+$25K	﹤0.01%	1986

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Glenmede Trust's INSM Position: Q1 2026 in Review

Glenmede Trust increased its Insmed (INSM) stake by 5.4% in Q1 2026, buying an estimated $15.1K and bringing the position to 1,916 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

Glenmede Trust first reported a position in INSM in Q4 2018 and has held it in 12 quarters since. The position peaked at $881K in Q1 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Glenmede Trust held 1,916 shares of Insmed worth $313K as of Q1 2026.
Glenmede Trust bought 98 Insmed shares in Q1 2026, an estimated $15.1K.
Insmed made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1138 holding.
Glenmede Trust first reported a position in Insmed in Q4 2018 and has held it in 12 quarters since.
Glenmede Trust's Insmed position peaked at $881K in Q1 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.